000 | 01444 a2200421 4500 | ||
---|---|---|---|
005 | 20250518070606.0 | ||
264 | 0 | _c20200928 | |
008 | 202009s 0 0 eng d | ||
022 | _a1462-0332 | ||
024 | 7 |
_a10.1093/rheumatology/kez518 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHamann, Philip D H | |
245 | 0 | 0 |
_aEarly response to anti-TNF predicts long-term outcomes including sustained remission: an analysis of the BSRBR-RA. _h[electronic resource] |
260 |
_bRheumatology (Oxford, England) _c07 2020 |
||
300 |
_a1709-1714 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
650 | 0 | 4 |
_aArthritis, Rheumatoid _xdiagnosis |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRegistries |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTumor Necrosis Factor Inhibitors _xtherapeutic use |
700 | 1 | _aPauling, John D | |
700 | 1 | _aMcHugh, Neil | |
700 | 1 | _aHyrich, Kimme | |
700 | 1 | _aShaddick, Gavin | |
773 | 0 |
_tRheumatology (Oxford, England) _gvol. 59 _gno. 7 _gp. 1709-1714 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/rheumatology/kez518 _zAvailable from publisher's website |
999 |
_c30300661 _d30300661 |